Lecturers by gender. حسب Ignacio García-Espona (21395335)

الموضوعات:

Posters by gender. حسب Ignacio García-Espona (21395335)

الموضوعات:

S2 File - Factors influencing effective decrease of controlled attenuation parameters in metabolic-associated steatotic liver disease: A multilevel linear regression analysis at Va... حسب Sonsawan Sangprasert (22772538)

Map of Zimbabwe highlighting the districts detected as persistent hotspots of <i>S. haematobium</i> prevalence (PPHS), persistent hotspots of decreased praziquantel efficacy (EPHS)... حسب Takafira Mduluza (39754)

Box plots showing baseline prevalence and mean egg count at pre-MDA1 in districts that were responders compared to those that were persistent hotspots of decreasing praziquantel ef... حسب Takafira Mduluza (39754)

Study-related adverse events. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study flow chart. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study CONSORT diagram. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Distribution of continuous variables of all 3 visits of group 1 (placebo) and group 2 (placebo) that have no significant difference among the groups. حسب Nattapon Riengvirodkij (11268720)

الموضوعات:

Decreasing oxygen saturation with corresponding levels of NLR and D-dimer for understanding the interplay of inflammation. حسب Narendran Gopalan (110148)

Drugs used in alcohol dependence (N07BB) prescribing changes from 2014 to 2022 (both genders). حسب Dainty Ei (22265317)

الموضوعات:

Regional differences in percentage changes of N07BB drug prescribing rates during the pandemic (both genders). حسب Dainty Ei (22265317)

الموضوعات:

Degeneration Saline group presented with significant decreased final weight in relation to other groups. حسب Flavia Gomes Velasque Gama (21175112)

Aripiprazole significantly decreases phosphorylated Src (Y416) levels in dHL-60 cells. حسب Courtney A. Swain (15170264)

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Primary and secondary efficacy end points (intention-to-treat population). حسب Benjamin R. Lewis (22279166)

الموضوعات:

Demographic and clinical characteristics of participants at baseline. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in Demoralization Scale (DSII) by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات: